Cargando…

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction

Highly sensitive mutation detection methods enable the application of circulating cell‐free DNA for molecular tumor profiling. Recent studies revealed that sequencing artifacts, germline variants, and clonal hematopoiesis confound the interpretation of sequencing results and complicate subsequent tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Leest, Paul, Schuuring, Ed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053232/ https://www.ncbi.nlm.nih.gov/pubmed/32017376 http://dx.doi.org/10.1002/1878-0261.12646

Ejemplares similares

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2020)

New approaches for detecting cancer with circulating cell-free DNA
por: Fiala, Clare, et al.
Publicado: (2019)

Plasma cell‐free DNA analysis for COVID‐19 and beyond
por: Ju, Jia, et al.
Publicado: (2022)

Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
por: van 't Erve, Iris, et al.
Publicado: (2023)

Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells
por: van Rossum, Agnes GSH, et al.
Publicado: (2005)

DNA methylation signatures in circulating cell-free DNA for the monitoring of at-risk populations progressing to lung cancer
por: Tost, Jörg
Publicado: (2015)

The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma
por: Yuwono, Nicole Laurencia, et al.
Publicado: (2021)

Diagnostic potential of circulating cell-free DNA in patients needing mechanical ventilation: promises and challenges
por: Arnalich, Francisco, et al.
Publicado: (2011)

Targeted Sequencing Analysis of Matched Cell-Free DNA and White Blood Cells: A Facile Method for Detection of Residual Disease in Gastric Cancer
por: Diao, Feiyu
Publicado: (2020)

Towards a more sensitive detection of somatic mutations in cell-free DNA
por: Earl, Julie
Publicado: (2019)

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
por: Mack, Elisabeth K. M., et al.
Publicado: (2022)

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study
por: Lamy, Pierre-Jean, et al.
Publicado: (2020)

Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia
por: Benamu, Esther, et al.
Publicado: (2021)

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
por: Razavi, Pedram, et al.
Publicado: (2019)

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2023)

Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA
por: Sun, Peng, et al.
Publicado: (2019)

ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack
por: Mooradian, Meghan J., et al.
Publicado: (2017)

Cell-free DNA and outcome in sepsis
por: Rhodes, Andrew, et al.
Publicado: (2012)

Plasma circulating cell-free mitochondrial DNA in depressive disorders
por: Fernström, Johan, et al.
Publicado: (2021)

KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control
por: Le Calvez-Kelm, Florence, et al.
Publicado: (2016)

Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
por: van der Leest, Paul, et al.
Publicado: (2021)

Is targeting circulating T blood cells a therapeutic option for vitiligo?
por: Matos, T.R.
Publicado: (2020)

Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
por: Morgan, Shethah R., et al.
Publicado: (2012)

Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma
por: Breitbach, Sarah, et al.
Publicado: (2014)

Simultaneous Discovery of Cell-Free DNA and the Nucleosome Ladder
por: Henikoff, Steven, et al.
Publicado: (2018)

Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
por: de Vos, Luka, et al.
Publicado: (2017)

Bisulfite Amplicon Sequencing Can Detect Glia and Neuron Cell-Free DNA in Blood Plasma
por: Chatterton, Zac, et al.
Publicado: (2021)

The struggle to detect circulating DNA
por: Zeerleder, Sacha
Publicado: (2006)

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
por: Primerano, Simona, et al.
Publicado: (2016)

Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma
por: Warton, Kristina, et al.
Publicado: (2014)

Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood
por: Gyanchandani, Rekha, et al.
Publicado: (2018)

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
por: Leal, Alessandro, et al.
Publicado: (2020)

Circulating cell-free nucleic acids as potential biomarkers for sarcopenia: a step toward personalized medicine
por: Shafiee, Gita, et al.
Publicado: (2017)

William Harvey and the discovery of the circulation of the blood
por: Ribatti, Domenico
Publicado: (2009)

Blood platelets: Circulating mirrors of neurons?
por: Canobbio, Ilaria
Publicado: (2019)

Targeted Next-Generation Sequencing of Endometrial Cancer and Matched Circulating Tumor DNA: Identification of Plasma-Based, Tumor-Associated Mutations in Early Stage Patients
por: Bolivar, Ana M., et al.
Publicado: (2018)

Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics
por: Jiao, Jingjing, et al.
Publicado: (2021)

Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients
por: Lieb, Verena, et al.
Publicado: (2021)

Circulating cell-free plasma tumour DNA shows a higher incidence of EGFR mutations in patients with extrathoracic disease progression
por: Seki, Yoshitaka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b6el1l3ms9cai96io9mb2764ar